Finland· FI-REL-REL61845

Caninda

A candesartan und diuretika product containing candesartan cilexetil + indapamide, registered in Finland by KRKA d.d. Novo mesto. The same ATC class is registered in 12 of our 19 countries.

ATC C09DA06

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedCanindaATCC09DA06REGISTER NO.FI-REL-REL61845PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Candesartan und diuretika is registered in 12 of 19 countries.

Countries holding a registration under ATC C09DA06 (candesartan und diuretika), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 8 of them publish a price we can compare per daily dose

Candesartan und diuretika · ATC C09DA06

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Candesartan cilexetil + Indapamide
Manufacturer
KRKA d.d. Novo mesto
Country
Finland (FI)
ATC code
C09DA06
ATC class
Candesartan und Diuretika
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 2

2 priced
  • fi_myyntilupa
    567838
    28
    EUR 14.36
  • fi_myyntilupa
    451965
    98
    EUR 44.28

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

80 interactions on record for candesartan und diuretika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Candesartan und diuretika · interactions on record

80 records

80 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Candesartan und diuretika in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All candesartan und diuretika products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Cyprus · Candexin
  • Germany · Candecor-Inda, Candeinda Apontis
  • Estonia · Kanpiduo
  • Spain · Kanpiduo
  • Hungary · Kanpi Duo
  • Lithuania · Kanpiduo
  • Latvia · Kanpiduo
  • Poland · Kanpiduo
  • Portugal · Candexin
  • Romania · Co-Karbis
  • Slovenia · Kanpiduo
  • Slovakia · Kanpiduo

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f2a1d182-7b0e-4459-9266-88563b6f6f56
GET /v1/drugs/f2a1d182-7b0e-4459-9266-88563b6f6f56?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "1",
  "form": "tabletti",
  "route": "Suun kautta",
  "ddd_unit": "ED",
  "strength": "16 mg / 2.5 mg",
  "atc_label": "kandesartaani ja diureetit",
  "ma_number": "42780",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL61845",
  "authorised_at": "2024-10-24"
}

See everything about candesartan und diuretika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.